NEOGEN’s acquisition of CAPInnoVet will provide entry into the fast-growing $12B+ retail parasiticide market
NEOGEN Corporation has recently acquired Atlanta-based CAPInnoVet, a companion animal health company that provides pet medications to the veterinary market. NEOGEN’s acquisition of CAPInnoVet will provide entry into the fast-growing $12B+ retail parasiticide market. CAPInnoVet will integrate into NEOGEN’s Animal Safety business segment, which includes veterinary instruments, pharmaceuticals, vaccines, and diagnostic products.
“The acquisition of CAPInnoVet provides NEOGEN a strategic pathway into the parasiticide market and naturally aligns within our Animal Safety business segment,” said Doug Jones, Chief Commercial Officer, NEOGEN.
“We are excited to be joining the NEOGEN team. Becoming a part of NEOGEN will allow us to not only further advance our vision of providing high-quality pet medications at a significant value to pet owners but also join a company that has similar values,” said Rudy Hauser, CAPInnoVet co-founder and CEO. “I would like to thank the CAPInnoVet team for their commitment and dedication to making this company a success. We are extremely appreciative of their contributions; we certainly would not have been this successful without them, and for that, we are deeply grateful.”
CAPInnoVet was founded in 2014 as a key provider of differentiated companion animal health products, providing better access to high-quality and high-value pet medications.
